The Effects of Jing Si Herbal Tea Liquid Packets on Fatigue in Patients With Inflammatory Arthritis
Primary Purpose
Arthritis, Rheumatoid Arthritis, Ankylosing Spondylitis
Status
Enrolling by invitation
Phase
Not Applicable
Locations
Taiwan
Study Type
Interventional
Intervention
Jing Si Herbal Tea LIQUID PACKETS
Placebo
Sponsored by
About this trial
This is an interventional treatment trial for Arthritis
Eligibility Criteria
Inclusion Criteria:
inflammatory arthritis, any of the following diagnosis
- Rheumatoid arthritis, based on ACR (American College of Rheumatology) classification criteria
- Ankylosing spondylitis, based on modified New York Criteria
- Psoriatic arthritis, based on 2006 CASPAR (ClASsification criteria for Psoriatic ARthritis) criteria
Exclusion Criteria:
- active infection or chronic infection
- uncontrolled disease status of inflammatory arthritis
- unwilling to take herbal tea
- with difficulty for return visits
Sites / Locations
- Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Placebo Comparator
Arm Label
Jing Si Herbal Tea LIQUID PACKETS
Placebo
Arm Description
one packet oral twice daily for three months
one packet oral twice daily for three months
Outcomes
Primary Outcome Measures
Change in level of fatigue [Time Frame: 4, 8, 12 weeks after Jing Si Herbal Tea Liquid Packets]
Fatigue assessment measured by the functional assessment of chronic illness Therapy- Fatigue (FACIT- F) (0-52; higher score=less fatigue)
Secondary Outcome Measures
Change in disease activity of inflammatory arthritis [Time Frame: 4, 8, 12 weeks after Jing Si Herbal Tea Liquid Packets]
Disease activity of inflammatory arthritis measured by the Disease Activity Score based on 28 joints (DAS28) (0-9.55; higher score=more active) for rheumatoid arthritis, Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) (0-10; higher score=more active) for ankylosing spondylitis, and Disease Activity in PSoriatic Arthritis (DAPSA) (0-204; higher score=more active) for psoriatic arthritis.
Full Information
NCT ID
NCT05257174
First Posted
January 28, 2022
Last Updated
July 25, 2023
Sponsor
Buddhist Tzu Chi General Hospital
1. Study Identification
Unique Protocol Identification Number
NCT05257174
Brief Title
The Effects of Jing Si Herbal Tea Liquid Packets on Fatigue in Patients With Inflammatory Arthritis
Official Title
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effects of Jing Si Herbal Tea Liquid Packets on Fatigue in Patients With Inflammatory Arthritis
Study Type
Interventional
2. Study Status
Record Verification Date
July 2023
Overall Recruitment Status
Enrolling by invitation
Study Start Date
June 15, 2022 (Actual)
Primary Completion Date
December 31, 2023 (Anticipated)
Study Completion Date
June 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Buddhist Tzu Chi General Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
Fatigue is a common feature in patients with rheumatic conditions. Fatigue can lead to a decline in physical function, self-confidence, cognitive status, and work performance and significantly impact the quality of life. While pain and inflammation of arthritis can be well controlled nowadays attributed to the advances in anti-rheumatic medications, fatigue remains a challenge. Even with proper therapies for arthritis, the prevalence of severe fatigue is more than 30%, which is a significant burden to both physicians and patients. However, there is no regimen to alleviate fatigue among patients with inflammatory arthritis. Finding a way to combat fatigue will significantly help improve patients' physical and mental state and family society.
To investigate the efficacy of Jing Si Herbal Tea Liquid Packets on fatigue in patients with inflammatory arthritis, the investigators propose a two-year research project to recruit approximately 150 patients with fatigue and inflammatory arthritis, including rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis. This project is designed as a randomized, double-blind, placebo-controlled study. The recruited patients will be randomized to receive Jing Si Herbal Tea Liquid Packets or a matching placebo in combination with the background regular anti-rheumatic therapy. The severity of fatigue will be obtained by questionnaire. Clinical parameters, including demographic data and disease activities, will be collected during each visit.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Arthritis, Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis, Fatigue
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
150 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Jing Si Herbal Tea LIQUID PACKETS
Arm Type
Experimental
Arm Description
one packet oral twice daily for three months
Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
one packet oral twice daily for three months
Intervention Type
Dietary Supplement
Intervention Name(s)
Jing Si Herbal Tea LIQUID PACKETS
Intervention Description
intake Jing Si Herbal Tea LIQUID PACKETS twice daily for three months
Intervention Type
Dietary Supplement
Intervention Name(s)
Placebo
Intervention Description
intake Placebo twice daily for three months
Primary Outcome Measure Information:
Title
Change in level of fatigue [Time Frame: 4, 8, 12 weeks after Jing Si Herbal Tea Liquid Packets]
Description
Fatigue assessment measured by the functional assessment of chronic illness Therapy- Fatigue (FACIT- F) (0-52; higher score=less fatigue)
Time Frame
Change of fatigue level every 4 weeks until 12 weeks after Jing Si Herbal Tea Liquid Packets
Secondary Outcome Measure Information:
Title
Change in disease activity of inflammatory arthritis [Time Frame: 4, 8, 12 weeks after Jing Si Herbal Tea Liquid Packets]
Description
Disease activity of inflammatory arthritis measured by the Disease Activity Score based on 28 joints (DAS28) (0-9.55; higher score=more active) for rheumatoid arthritis, Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) (0-10; higher score=more active) for ankylosing spondylitis, and Disease Activity in PSoriatic Arthritis (DAPSA) (0-204; higher score=more active) for psoriatic arthritis.
Time Frame
Change of disease activity every 4 weeks until 12 weeks after Jing Si Herbal Tea Liquid Packets
10. Eligibility
Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
99 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
inflammatory arthritis, any of the following diagnosis
Rheumatoid arthritis, based on ACR (American College of Rheumatology) classification criteria
Ankylosing spondylitis, based on modified New York Criteria
Psoriatic arthritis, based on 2006 CASPAR (ClASsification criteria for Psoriatic ARthritis) criteria
Exclusion Criteria:
active infection or chronic infection
uncontrolled disease status of inflammatory arthritis
unwilling to take herbal tea
with difficulty for return visits
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kuei-Ying Su, MD,PhD
Organizational Affiliation
Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
City
Hualien City
ZIP/Postal Code
970
Country
Taiwan
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
Data obtained through this study may be provided to qualified researchers with academic interest in fatigue among patients with inflammatory arthritis. Data or samples shared will be coded, with no PHI (protected health information) included. Approval of the request and execution of all applicable agreements (i.e. a material transfer agreement) are prerequisites to the sharing of data with the requesting party.
IPD Sharing Time Frame
Data requests can be submitted starting 9 months after article publication and the data will be made accessible for up to 24 months. Extensions will be considered on a case-by-case basis.
Citations:
PubMed Identifier
26272057
Citation
Overman CL, Kool MB, Da Silva JA, Geenen R. The prevalence of severe fatigue in rheumatic diseases: an international study. Clin Rheumatol. 2016 Feb;35(2):409-15. doi: 10.1007/s10067-015-3035-6. Epub 2015 Aug 15.
Results Reference
background
PubMed Identifier
32745130
Citation
Esbensen BA, Stallknecht SE, Madsen ME, Hagelund L, Pilgaard T. Correlations of fatigue in Danish patients with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis. PLoS One. 2020 Aug 3;15(8):e0237117. doi: 10.1371/journal.pone.0237117. eCollection 2020.
Results Reference
background
Learn more about this trial
The Effects of Jing Si Herbal Tea Liquid Packets on Fatigue in Patients With Inflammatory Arthritis
We'll reach out to this number within 24 hrs